These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35751380)

  • 1. Endoscopic surgery is superior to intensity-modulated radiotherapy in the treatment of advanced recurrent nasopharyngeal carcinoma.
    Li W; Zhang Q; Chen F; Xu H; Liu Q; Wang H; Zhang H; Liu Q; Gu Y; Li H; Sun X; Yu H; Wang D
    Int Forum Allergy Rhinol; 2023 Feb; 13(2):140-150. PubMed ID: 35751380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage endoscopic nasopharyngectomy and intensity-modulated radiotherapy versus conventional radiotherapy in treating locally recurrent nasopharyngeal carcinoma.
    Zou X; Han F; Ma WJ; Deng MQ; Jiang R; Guo L; Liu Q; Mai HQ; Hong MH; Chen MY
    Head Neck; 2015 Aug; 37(8):1108-15. PubMed ID: 24764204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoscopic surgery versus intensity-modulated radiotherapy in locally advanced recurrent nasopharyngeal carcinoma: a multicenter, case-matched comparison.
    Liu Y; Huang N; Gao J; He B; Huang H; Wan L; Cai Q; Zhu Z; Zhou S; Wang J; Wang X; Qiu Q; Han F
    J Otolaryngol Head Neck Surg; 2023 Nov; 52(1):72. PubMed ID: 37932841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Radiotherapy Combined With Chemotherapy on Long-Term Outcomes of Patients With Recurrent Nasopharyngeal Carcinoma.
    Li Y; Liu W; Xu Y; Guo LY; Weng YL; Huang ZW; Chen XC; Lin T; Lu J; Qiu SF
    Technol Cancer Res Treat; 2023; 22():15330338231155721. PubMed ID: 36762400
    [No Abstract]   [Full Text] [Related]  

  • 5. IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma : Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06).
    Moon SH; Cho KH; Lee CG; Keum KC; Kim YS; Wu HG; Kim JH; Ahn YC; Oh D; Lee JH
    Strahlenther Onkol; 2016 Jun; 192(6):377-85. PubMed ID: 26972085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic factors of conformal radiotherapy versus intensity-modulated radiotherapy for nasopharyngeal carcinoma.
    Kuang WL; Zhou Q; Shen LF
    Clin Transl Oncol; 2012 Oct; 14(10):783-90. PubMed ID: 22855156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage endoscopic nasopharyngectomy is superior to intensity-modulated radiation therapy for local recurrence of selected T1-T3 nasopharyngeal carcinoma – A case-matched comparison.
    You R; Zou X; Hua YJ; Han F; Li L; Zhao C; Hong MH; Chen MY
    Radiother Oncol; 2015 Jun; 115(3):399-406. PubMed ID: 25987536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intensity modulated radiotherapy with simultaneous integrated boost (IMRT-SIB) and a 3-dimensional conformal parotid gland-sparing radiotherapy (ConPas 3D-CRT) in treatment of nasopharyngeal carcinoma: a mono-institutional experience.
    Bišof V; Rakušić Z; Bibić J; Grego T; Soče M
    Radiol Med; 2018 Mar; 123(3):217-226. PubMed ID: 29094268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up.
    Zhang MX; Li J; Shen GP; Zou X; Xu JJ; Jiang R; You R; Hua YJ; Sun Y; Ma J; Hong MH; Chen MY
    Eur J Cancer; 2015 Nov; 51(17):2587-95. PubMed ID: 26318726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
    Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
    Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
    Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
    J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic surgery compared with intensity-modulated radiotherapy in resectable locally recurrent nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
    Liu YP; Wen YH; Tang J; Wei Y; You R; Zhu XL; Li J; Chen L; Ling L; Zhang N; Zou X; Hua YJ; Chen YM; Chen L; Lu LX; Chen MY; Wen WP
    Lancet Oncol; 2021 Mar; 22(3):381-390. PubMed ID: 33600761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of clinical prognosis of endoscopic salvage surgery in patients with rT2 recurrent nasopharyngeal carcinoma].
    Song XL; Li WP; Yang JY; Zhang HK; Wang H; Xue K; Liu Q; Sun XC; Yu HM; Wang DH
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Dec; 57(12):1442-1449. PubMed ID: 36707948
    [No Abstract]   [Full Text] [Related]  

  • 15. The Changing Therapeutic Role of Chemo-radiotherapy for Loco-regionally Advanced Nasopharyngeal Carcinoma from Two/Three-Dimensional Radiotherapy to Intensity-Modulated Radiotherapy: A Network Meta-Analysis.
    You R; Cao YS; Huang PY; Chen L; Yang Q; Liu YP; Zou X; Zhang YN; Jiang R; Zhang MX; Duan CY; Lin AH; Hong MH; Chen MY
    Theranostics; 2017; 7(19):4825-4835. PubMed ID: 29187906
    [No Abstract]   [Full Text] [Related]  

  • 16. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study.
    Lin Q; Lu L; Wang X; Lin Y; Chen Y; Chen H; Chen S; Lin S; Zhang Y; Zheng P; Chen X
    Am J Otolaryngol; 2022; 43(1):103193. PubMed ID: 34509080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of recurrent nasopharyngeal carcinoma patients treated with endoscopic nasopharyngectomy: a meta-analysis.
    Yang J; Song X; Sun X; Liu Q; Hu L; Yu H; Wang D
    Int Forum Allergy Rhinol; 2020 Aug; 10(8):1001-1011. PubMed ID: 32452124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-Year Results of Therapeutic Ratio by Intensity-Modulated Radiotherapy Versus Two-Dimensional Radiotherapy in Patients with Nasopharyngeal Carcinoma.
    Chen L; Zhang Y; Lai SZ; Li WF; Hu WH; Sun R; Liu LZ; Zhang F; Peng H; Du XJ; Lin AH; Sun Y; Ma J
    Oncologist; 2019 Jan; 24(1):e38-e45. PubMed ID: 30082487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Management of rNPC: Salvage Surgery vs. Re-irradiation.
    Hao CY; Hao SP
    Curr Oncol Rep; 2020 Jul; 22(9):86. PubMed ID: 32642860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
    Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
    Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.